Food and Drug Administration Commissioner Scott Gottlieb, M.D., today reviewed actions the agency is taking to address the increased shortages of sodium chloride injection bags and other saline intravenous fluids used in hospital and outpatient settings since Hurricane Maria impacted production facilities in Puerto Rico. The actions include efforts to temporarily import products from other countries, expand production at existing facilities, expedite review of new product applications, and encourage the island to prioritize access to the electrical grid for critical facilities. Gottlieb also encouraged health care providers to consider recent guidance from the American Society of Health-System Pharmacists and others for managing the shortages and discouraged product hoarding. AHA and others have urged FDA and Congress to quickly resolve the shortages and develop a comprehensive strategy to manage such situations moving forward. In other news, the Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response has launched a webpage highlighting its resources to help stakeholders prepare for and manage drug shortages and allocate scarce resources.

Related News Articles

Headline
The AHA today submitted to the Food and Drug Administration legislative, regulatory and best practice recommendations to address new and chronic prescription…
Headline
The Food and Drug Administration yesterday released revised draft guidance for facilities that compound human drugs as outsourcing facilities.
Headline
The AHA, American Society of Anesthesiologists, American Society of Clinical Oncology, American Society of Health-System Pharmacists, and Institute for Safe…
Headline
The Food and Drug Administration yesterday warned the health care community about complications that arise when pairing pain medications with intrathecal…
Headline
Oct. 27 is National Prescription Drug Take Back Day, an opportunity for the public to safely dispose of unwanted or expired prescription pills at sites…
Headline
The Food and Drug Administration yesterday released a series of guidance documents intended to help manufacturers develop generic transdermal and topical…